Medpace Holdings (MEDP) Non-Current Deferred Tax Liability (2015 - 2026)
Medpace Holdings (MEDP) posted Non-Current Deferred Tax Liability of $3.9 million for Q1 2026, up 189.67% quarter-over-quarter from $1.4 million in Q4 2025, and up 113.55% year-on-year from $1.8 million in Q1 2025.
Medpace Holdings (MEDP) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Non-Current Deferred Tax Liability for 12 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $3.9 million, up 113.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (up 113.55% YoY), and the FY2025 annual result was $1.4 million, down 24.72% from the prior year.
- Non-Current Deferred Tax Liability was $3.9 million for Q1 2026 at Medpace Holdings, up from $1.4 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $47.1 million in Q4 2022 and troughed at $911000.0 in Q3 2022.
- Average Non-Current Deferred Tax Liability over 5 years is $4.4 million, with a median of $1.8 million recorded in 2025.
- Year-over-year, Non-Current Deferred Tax Liability surged 4264.17% in 2022 and sank 94.9% in 2023.
- Over 5 years, Non-Current Deferred Tax Liability stood at $47.1 million in 2022, then tumbled by 94.9% to $2.4 million in 2023, then dropped by 25.12% to $1.8 million in 2024, then retreated by 24.72% to $1.4 million in 2025, then surged by 189.67% to $3.9 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $3.9 million in Q1 2026, $1.4 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Medpace Holdings | 15.46 Bn | 14.81 Bn | 196.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Dec 31, 2023 | 2.40 Mn |